Neuropace, Inc.

From Neuropace's results release of 12 Kasım 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.

• Revenue

  Actual

  $23,1M

  -%16 y/y ↓
  +%1,2 q/q ↑

  Guided

  —

  No guide given

• Operating income, adjusted

  Actual

  $400K

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.